Bristol Myers Squibb announced an expansion of its direct-to-patient offerings, providing eligible US patients with steeply discounted prices for Eliquis (apixaban) and Sotyktu (deucravacitinib).

During the event, the Chairman of the Board gave guests a peek at what’s next for the brand, but it also turned into something of a pronunciation lesson. “David Marriott, Chairman of the Board, on the ...

One of the perks of traveling and sight-seeing—or of eating out in a big city or a food festival—is the opportunity to try dishes from countries and cultures far outside your own. Of course, some ...

Doctors commonly prescribe Eliquis to prevent strokes and blood clots in people with a particular type of irregular heartbeat called atrial fibrillation (AFib). Many Medicare Part D prescription drug ...

President Donald Trump announced a new—and incorrect—way to pronounce a common biblical name on Monday. Speaking ahead of Israeli Prime Minister Benjamin Netanyahu at the White House on Monday, Trump, ...

David Marriott, chairman of the board of directors at Marriott International, revealed we've been saying the name of the hotel chain wrong this whole time. Marriott was speaking during Marriott Bonvoy ...

Marriott may be one of the most successful hotel chains in the world - but, according to the chairman, everyone's been pronouncing its name wrong this whole time. David Marriott, whose grandfather JW ...

Invest 94L southeast of Florida in the Caribbean is expected to become a tropical depression over the weekend. If it continues to strengthen, it could become the next named storm: Imelda. Here's how ...

Bristol Myers Squibb and Pfizer have launched an online programme to sell their blockbuster anticoagulant Eliquis directly to patients, following in the footsteps of Eli Lilly and Novo Nordisk in a ...

President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...

WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.